← Product Code [LLZ](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ) · K093982 # XELERIS 3 PROCESSING AND REVIEW WORKSTATION (K093982) _Ge Medical Systems F.I. Haifa · LLZ · Jan 8, 2010 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K093982 ## Device Facts - **Applicant:** Ge Medical Systems F.I. Haifa - **Product Code:** [LLZ](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ.md) - **Decision Date:** Jan 8, 2010 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.2050 - **Device Class:** Class 2 - **Review Panel:** Radiology - **Attributes:** Software as a Medical Device, 3rd-Party Reviewed ## Intended Use The system is intended for use by Nuclear Medicine (NM) or Radiology practitioners and referring physicians for display, processing, archiving, printing, reporting and networking of NM data including planar scans (Static, Whole Body, Dynamic, Multi-Gated) and tomographic scans (SPECT, Gated SPECT, dedicated PET or Camera-Based-PET) acquired by gamma cameras or PET scanners. The system can run on dedicated workstation or in a server-client configuration. The NM or PET data can be coupled with registered and/or fused CT or MR scans and with physiological signals, in order to: depict, localize, and/or quantify the distribution of radionuclide tracers and anatomical structures in scanned body tissue for clinical diagnostic purposes. ## Device Story Xeleris 3 is a nuclear medicine workstation software for display, processing, archiving, and networking of NM, PET, NM/CT, and PET/CT studies. Inputs include planar scans (static, dynamic, gated, whole body) and tomographic scans (SPECT, PET) from gamma cameras or PET scanners; data may be fused with CT/MR scans and physiological signals. Operated by physicians or technologists in clinical settings; runs on Windows XP-based PC or client-server configurations. Output includes processed images and reports used by clinicians to depict, localize, and quantify radionuclide tracer distribution and anatomical structures. Facilitates clinical decision-making by providing diagnostic visualization and quantification tools. ## Clinical Evidence Bench testing only; no clinical data. ## Technological Characteristics Windows XP-based PC workstation; supports client-server configuration. Connectivity via Ethernet; complies with DICOM standards. Hardware includes color monitor, keyboard, mouse, and CD-RW/DVD for archiving. Software-based image processing and review system. ## Regulatory Identification A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements. ## Special Controls *Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern). ## Predicate Devices - XELERIS 2 PROCESSING AND REVIEW WORKSTATION ([K051673](/device/K051673.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## 510(k) Summary ## JAN - 8 2010 1093982 In accordance with 21 CFR 807.92 the following summary of information is provided: Date: October ,8,2009 Submitter: GE Healthcare, GE Medical Systems Israel, Functional Imaging 4 HAYOZMA St TIRAT HACARMEL, 30200, ISRAEL Primary Contact Person: Eli Werner Regulatory Affairs Leader GE Healthcare, GE Medical Systems Israel, Functional Imaging +972-4-8563666 +972-4-8563664 Secondary Contact Person: Laurence Bigio OA site manager GE Healthcare, GE Medical Systems Israel, Functional Imaging +972-4-8563666 +972-4-8563664 Device: Trade Name: XELERIS 3 PROCESSING AND REVIEW WORKSTATION Common/Usual Name: Nuclear Medicine Workstation Classification Names: System, Image Processing, Radiological Class II :21CFR 892.2050 LLZ Product Code: Predicate Device(s): K051673 XELERIS 2 PROCESSING AND REVIEW WORKSTATION XELERIST™ 3 PROCESSING AND REVIEW WORKSTATION Device Description: (Xeleris 3), as a modification of its predicate device - Xeleris 2 (K051673), is a Nuclear Medicine, PET, NM/CT, and PET/CT workstation. Xeleris 3, as a medical device, is computer workstation software used for the display, processing, archiving, printing, reporting and networking of NM, PET, NM/CT, and PET/CT studies. Xeleris 3 runs on Microsoft Windows XP based PC workstation (color monitor, keyboard, mouse, and CD-RW for archiving), an Ethernet network connection and system software. Optional DVD device is also available. Xeleris 3 also operates in client-server configurations. Xeleris 3 is classified as class II medical device, complies with voluntary Digital Imaging and Communication in Medicine (DICOM) standard. {1}------------------------------------------------ - Intended Use: The system is intended for use by Nuclear Medicine (NM) or Radiology practitioners and referring physicians for display, processing , archiving, printing, reporting and networking of NM data including planar scans (Static, Whole Body, Dynamic, Multi-Gated) and tomographic scans (SPECT, Gated SPECT, dedicated PET or Camera-Based-PET) acquired by gamma cameras or PET scanners. The system can run on dedicated workstation or in a server-client configuration. The NM or PET data can be coupled with registered and/or fused CT or MR scans and with physiological signals, in order to: depict, localize, and/or quantify the distribution of radionuclide tracers and anatomical structures in scanned body tissue for clinical diagnostic purposes. ## The "XELERIS 3 PROCESSING AND REVIEW Technology: WORKSTATION" employs the same fundamental scientific technology as its predicate devices "XELERIS 2 PROCESSING AND REVIEW WORKSTATION (K051673)". AND Determination of ని PROCESSING The XELERIS REVIEW Substantial Equivalence: WORKSTATION and its applications is designed to comply with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance measures were applied to the development of the system: > Risk Analysis Requirements Reviews Design Reviews Testing on unit level (Module verification) Integration testing (System verification) Final acceptance testing (Validation) Performance testing (Verification) Safety testing (Verification) 3 PROCESSING AND REVIEW The XELERIS WORKSTATION did not require clinical studies to support substantial equivalence. Conclusion: GE Healthcare considers the "XELERIS 3 PROCESSING AND REVIEW WORKSTATION" to be as safe, as effective, and performance is substantially equivalent to the predicate device(s) "XELERIS 2 PROCESSING AND REVIEW WORKSTATION (K051673)". {2}------------------------------------------------ Image /page/2/Picture/0 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002 GE Healthcare, GE Medical Systems Israel % Mr. Casey Conry Senior Project Engineer Underwriters Laboratories, Inc 1285 Walt Whitman Rd. MELVILLE NY 11747 - JAN - 8 2010 Re: K093982 Trade/Device Name: Xeleris 3 Processing and Review Workstation Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: December 22, 2009 Received: December 24, 2009 Dear Mr. Conry: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, .. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical - {3}------------------------------------------------ Page 2 - device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. http://www.fda.gov/MedicalDevices/ResourceforYou/Industry/default.htm. Sincerely yours, Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): Image /page/4/Picture/1 description: The image shows the text "K093982" at the top. Below this text is another line of text that is crossed out. The crossed-out text appears to say "INSERT STOCK NUMBER IF KNOWN". The text is in all caps and is surrounded by a rectangular box. Device Name: XELERIS 3 PROCESSING AND REVIEW WORKSTATION Indications for Use: The system is intended for use by Nuclear Medicine (NM) or Radiology practitioners and referring physicians for display, processing, archiving, reporting and networking of NM data including planar scans (Static, Whole Body, Dynamic, Multi-Gated) and tomographic scans (SPECT, Gated SPECT, dedicated PET or Camera-Based-PET) acquired by gamma cameras or PET scanners. The system can run on dedicated workstation or in a server-client configuration. The NM or PET data can be coupled with registered and/or fused CT or MR scans and with physiological signals, in order to: depict, localize, and/or quantify the distribution of radionuclide tracers and anatomical structures in scanned body tissue for clinical diagnostic purposes. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use_ (Part 21 CFR 801 Subpart C) ## (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devic 510(k) Number. --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K093982](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/LLZ/K093982) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com